Vol 4, No 8 (April 2016): Annals of Translational Medicine (Lung Cancer Screening)

Editorial

Lung cancer screening moving forward

Witold Rzyman, James L. Mulshine

PDF Full Text Open Access

Review Article

Lung cancer epidemiology: contemporary and future challenges worldwide

Joanna Didkowska, Urszula Wojciechowska, Marta Mańczuk, Jakub Łobaszewski

PDF Full Text Open Access

Risk factors assessment and risk prediction models in lung cancer screening candidates

Mariusz Adamek, Ewa Wachuła, Sylwia Szabłowska-Siwik, Agnieszka Boratyn-Nowicka, Damian Czyżewski

PDF Full Text Open Access

Implementation and organization of lung cancer screening

Jesper Holst Pedersen, Haseem Ashraf

PDF Full Text Open Access

The importance of the regimen of screening in maximizing the benefit and minimizing the harms

Claudia I. Henschke, Kunwei Li, Rowena Yip, Mary Salvatore, David F. Yankelevitz

PDF Full Text Open Access

Advancing and sharing the knowledge base of CT screening for lung cancer

David F. Yankelevitz, Claudia I. Henschke

PDF Full Text Open Access

2016 reflections on the favorable cost-benefit of lung cancer screening

Bruce Pyenson, Gabriela Dieguez

PDF Full Text Open Access

Management of CT screen-detected lung nodule: the thoracic surgeon perspective

Adnan M. Al-Ayoubi, Raja M. Flores

PDF Full Text Open Access

Smoking cessation and lung cancer screening

Jesper Holst Pedersen, Philip Tønnesen, Haseem Ashraf

PDF Full Text Open Access

Biomarkers of risk to develop lung cancer in the new screening era

Thomas Atwater, Pierre P. Massion

PDF Full Text Open Access

Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?

Joseph Shemesh

PDF Full Text Open Access

Lung cancer screening in patients with chronic obstructive pulmonary disease

Jessica Gonzalez, Marta Marín, Pablo Sánchez-Salcedo, Javier J. Zulueta

PDF Full Text Open Access

Disclosure:

The focused issue“Lung Cancer Screening” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Witold Rzyman and James L. Mulshine served as the unpaid Guest Editors for the focused issue.